Page last updated: 2024-08-23

atomoxetine hydrochloride and Abnormalities, Drug-Induced

atomoxetine hydrochloride has been researched along with Abnormalities, Drug-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bateman, BT; Bröms, G; Einarsdóttir, K; Engeland, A; Furu, K; Gissler, M; Hernandez-Diaz, S; Huybrechts, KF; Karlsson, P; Kieler, H; Klungsøyr, K; Kristiansen, EB; Lahesmaa-Korpinen, AM; Mogun, H; Nørgaard, M; Reutfors, J; Sørensen, HT; Zoega, H1
Garcia-Bournissen, F; Humphreys, C; Ito, S; Koren, G1

Reviews

1 review(s) available for atomoxetine hydrochloride and Abnormalities, Drug-Induced

ArticleYear
Exposure to attention deficit hyperactivity disorder medications during pregnancy.
    Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:7

    Topics: Abnormalities, Drug-Induced; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Congenital Abnormalities; Decision Making; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Methylphenidate; Pregnancy; Pregnancy Complications; Propylamines; Risk Assessment

2007

Other Studies

1 other study(ies) available for atomoxetine hydrochloride and Abnormalities, Drug-Induced

ArticleYear
Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study.
    The Journal of clinical psychiatry, 2023, 01-16, Volume: 84, Issue:1

    Topics: Abnormalities, Drug-Induced; Atomoxetine Hydrochloride; Cohort Studies; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Pregnancy; Pregnancy Trimester, First; Prevalence

2023